Australian Pharmacist

A major new PSA report, Pharmacists in 2023, reveals a roadmap for the changes needed to ensure the profession’s potential is realised – and...

The effectiveness of systemic corticosteroids for the management of dyspnoea in adults with advanced cancer. Dyspnoea affects almost 70% of advanced cancer patients at the...

At PSA19 this morning, it was revealed that a Memorandum of Understanding (MoU) was signed by PSA and the Society of Hospital Pharmacists of...

NSW has granted pharmacists a landmark special authority to supply most S4 medicines without a prescription to those affected by bushfires. The NSW Chief Health...

I have just returned from FIP’s World Congress of Pharmacy and Pharmaceutical Sciences in Seville, where PSA CEO Mark Kinsela, PSA Senior Pharmacist Peter...

PSA introduced the new crop of leaders for the ECP Community of Specialty Interest to empower the next generation of pharmacists.